Dear Contractor
Please see attached correspondence in relation to a grant funding allocation relating to DM+D clinical system amendment.

ACTION

Contractors are advised to:

  • Note the correspondence from SPPG Pharmacy & Medicines Management team; and
  • Complete the form at Appendix A and return it to your local SPPG Primary Care Office by Friday 25th November 2022.

Please contact a member of the CPNI team should you have any queries.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

SECURING PERSONAL AND BUSINESS EMAILS AND MEDIA ACCOUNTS

As part of Cyber Security month, the PSNI Cyber Crime Centre and partners have been raising awareness of the steps that can be taken to secure personal email and social media accounts from being ‘hacked’.
 
As the most reported cyber-dependent crime by individuals in NI and the UK as a whole, the ‘hacking’ or compromise of an email or social media account can lead to the loss of personal information, images and potentially lead to the targeting or friends, family or work colleagues by an attacker using your account.
 
The attached document issued by the PSNI Cyber Crime Centre offers advice on securing your accounts.

ACTION

Contractors are advised to:

  • Read the attached information sheet and to take the appropriate actions to secure any relevant personal and business accounts; and
  • Raise staff awareness as to the importance of cyber security.

Further information can be accessed via the New Cyber Protect webpage HERE.

Kind regards – Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs 

This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS

CPNI ALERTS

DOH(NI) ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
The final update of concessionary prices were granted today for October 2022:
DrugPack SizeConcessionary Price
Aripiprazole 1mg/ml oral solution150£104.90
Bumetanide 1mg/5ml oral solution sugar free150£235.00
Chlorphenamine 2mg/5ml oral solution150£4.09
Chlorphenamine 2mg/5ml oral solution sugar free150£2.80
Cilostazol 100mg tablets56£14.99
Clobazam 10mg/5ml oral suspension sugar free56£90.28
Clobazam 10mg/5ml oral suspension sugar free250£150.46
Co-amilofruse 2.5mg/20mg tablets28£3.90
Docusate 50mg/5ml oral solution sugar free300£20.25
Doxycycline 100mg capsules8£0.85
Fluoxetine 40mg capsules30£2.47
Hydralazine 25mg tablets56£4.57
Ivabradine 5mg tablets56£6.70
Liothyronine 5microgram tablets28£100.94
Methotrexate 2.5mg tablets28£1.68
Mometasone 0.1% cream100£9.48
Nadolol 80mg tablets28£9.00
Nebivolol 10mg tablets28£28.18
Rabeprazole 20mg gastro-resistant tablets28£11.84
Rivastigmine 3mg capsules28£4.75
Yellow soft paraffin solid500£5.65
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE

Chief Executive
Dear Colleague
The fifth update of concessionary prices were granted today for October 2022:
DrugPack SizeConcessionary Price
Aripiprazole 15mg tablets28£36.80
Aripiprazole 5mg tablets28£37.78
Carbocisteine 375mg capsules120£17.04
Chloramphenicol 1% eye ointment4£3.38
Citalopram 20mg tablets28£1.96
Clindamycin 150mg capsules24£4.42
Codeine 30mg tablets100£3.96
Codeine 30mg tablets28£1.11
Co-trimoxazole 80mg/400mg tablets28£5.15
Digoxin 125microgram tablets28£1.53
Digoxin 62.5microgram tablets28£3.83
Gabapentin 300mg capsules100£3.33
Ibandronic acid 150mg tablets1£1.80
Levetiracetam 100mg/ml oral solutionsugar free300£9.15
Mometasone 0.1% cream30£4.32
Mometasone 0.1% ointment30£4.19
Mometasone 50micrograms/dose nasal spray140£3.71
Pregabalin 75mg capsules56£1.83
Quinine sulfate 200mg tablets28£3.97
Risperidone 500microgram tablets20£3.55
Temazepam 20mg tablets28£29.95
Tetracycline 250mg tablets28£14.39
Venlafaxine 37.5mg tablets56£3.53
Venlafaxine 75mg tablets56£16.14
Zolmitriptan 2.5mg tablets12£22.01
Zolmitriptan 2.5mg tablets6£11.01
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE

Chief Executive

Dear Contractor

PSNI CONSULTATION: DRAFT GUIDANCE ON PHARMACY STAFFING LEVELS

On 14 October 2022, PSNI issued an eight-week public consultation on “Draft Guidance on Pharmacy Staffing Levels” which closes on 9 December 2022.  This is very similar in format and content to GPhC guidance issued in 2018.

CPNI will be responding to the consultation questions and would welcome any initial comments which you may have to inform this response.

PSNI CONSULTATION: DRAFT GUIDANCE ON PHARMACY STAFFING LEVELS CALL FOR EVIDENCE: REVIEW OF THE CODE OF CONDUCT, ETHICS AND PERFORMANCE 2016

The Pharmaceutical Society NI has begun a review of the Pharmaceutical Society NI Code (Professional Standards of Conduct, Ethics and Performance for pharmacists in Northern Ireland) 2016.  CPNI has secured a place on the Advisory Group associated with this review.

PSNI has issued a Call for Evidence HERE which will be used to inform the proposed revision (the Call for Evidence will close on the 30 November 2022). The draft revised Code will be the subject of a public consultation in early 2023.

Contractors may wish to respond to the Call for Evidence directly via the link provided in the document.  Alternatively, you can send comments to CPNI and these will be used to inform our input and response.

Kind regards – Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs